Cabariban, Baby Boy .

HRN: 26-80-35  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/29/2026
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
04/29/2026
05/06/2026
PO
4ml
Q 8 Hours
Intestinal Amoebiasis
Checking Initial Appropriateness 
04/29/2026
CEFUROXIME 750MG (VIAL)
04/29/2026
05/06/2026
IV
290 Mg
Q 8 Hours
UTI
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: